All You Need to Know About Haemonetics (HAE) Rating Upgrade to BuyZacks Investment Research • Tuesday
4 Biotech Stocks With Promising Late-Stage Drug Pipelines to Watch NowZacks Investment Research • 10/20/26
Strength Seen in Haemonetics (HAE): Can Its 17.5% Jump Turn into More Strength?Zacks Investment Research • 10/09/26
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2027 Results: November 5, 2026PRNewsWire • 09/30/26
Haemonetics (HAE) is a Top-Ranked Momentum Stock: Should You Buy?Zacks Investment Research • 09/24/26
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by HaemoneticsGlobeNewsWire • 09/15/26
HAE Stock Gains on Q1 Earnings & Revenue Beat, Fiscal '27 View UpZacks Investment Research • 08/14/26
Haemonetics (HAE) Reliance on International Sales: What Investors Need to KnowZacks Investment Research • 08/11/26